| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |